Works matching DE "EMPAGLIFLOZIN"

Results: 1046
    1
    2
    3
    4
    5

    Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.

    Published in:
    Acta Diabetologica, 2022, v. 59, n. 4, p. 575, doi. 10.1007/s00592-021-01823-6
    By:
    • Rai, Archana;
    • Connelly, Kim A.;
    • Verma, Subodh;
    • Mazer, C. David;
    • Teoh, Hwee;
    • Ng, Ming-Yen;
    • Roifman, Idan;
    • Quan, Adrian;
    • Pourafkari, Marina;
    • Jimenez-Juan, Laura;
    • Ramanan, Venkat;
    • Ge, Yin;
    • Deva, Djeven P.;
    • Yan, Andrew T.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.

    Published in:
    Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/9415313
    By:
    • Kobayashi, Kazuo;
    • Toyoda, Masao;
    • Kaneyama, Noriko;
    • Hatori, Nobuo;
    • Furuki, Takayuki;
    • Sakai, Hiroyuki;
    • Takihata, Masahiro;
    • Umezono, Tomoya;
    • Ito, Shun;
    • Suzuki, Daisuke;
    • Takeda, Hiroshi;
    • Kanamori, Akira;
    • Degawa, Hisakazu;
    • Yamamoto, Hareaki;
    • Machimura, Hideo;
    • Mokubo, Atsuko;
    • Chin, Keiichi;
    • Obana, Mitsuo;
    • Hishiki, Toshimasa;
    • Aoyama, Kouta
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35944-5
    By:
    • Silva dos Santos, Danúbia;
    • Turaça, Lauro Thiago;
    • Coutinho, Keyla Cristiny da Silva;
    • Barbosa, Raiana Andrade Quintanilha;
    • Polidoro, Juliano Zequini;
    • Kasai-Brunswick, Tais Hanae;
    • Campos de Carvalho, Antonio Carlos;
    • Girardi, Adriana Castello Costa
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects.

    Published in:
    Frontiers in Physiology, 2017, p. 1, doi. 10.3389/fphys.2017.01077
    By:
    • Andreadou, Ioanna;
    • Efentakis, Panagiotis;
    • Balafas, Evangelos;
    • Togliatto, Gabriele;
    • Davos, Constantinos H.;
    • Varela, Aimilia;
    • Dimitriou, Constantinos A.;
    • Nikolaou, Panagiota-Efstathia;
    • Maratou, Eirini;
    • Lambadiari, Vaia;
    • Ikonomidis, Ignatios;
    • Kostomitsopoulos, Nikolaos;
    • Brizzi, Maria F.;
    • Dimitriadis, George;
    • Iliodromitis, Efstathios K.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50